Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.46
+0.08 (0.56%)
At close: Jul 25, 2025, 4:00 PM
14.21
-0.25 (-1.73%)
After-hours: Jul 25, 2025, 6:07 PM EDT
Keros Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts that cover Keros Therapeutics stock have a consensus rating of "Buy" and an average price target of $20.63, which forecasts a 42.67% increase in the stock price over the next year. The lowest target is $15 and the highest is $26.
Price Target: $20.63 (+42.67%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 10, 2025.
Analyst Ratings
The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 6 | 6 | 7 | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $32 → $18 | Strong Buy → Hold | Downgrades | $32 → $18 | +24.48% | Jun 10, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | +3.73% | May 30, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $41 → $26 | Buy | Maintains | $41 → $26 | +79.81% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $25 | Strong Buy | Maintains | $40 → $25 | +72.89% | May 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $43 → $25 | Strong Buy | Maintains | $43 → $25 | +72.89% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
194.92M
from 3.55M
Increased by 5,390.70%
Revenue Next Year
19.77M
from 194.92M
Decreased by -89.86%
EPS This Year
-0.68
from -5.00
EPS Next Year
-4.31
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 242.8M | 101.3M | 108.4M | ||
| Avg | 194.9M | 19.8M | 23.7M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6,738.3% | -48.0% | 448.1% | ||
| Avg | 5,390.7% | -89.9% | 19.7% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.99 | -2.58 | -2.92 | ||
| Avg | -0.68 | -4.31 | -4.52 | ||
| Low | -4.54 | -5.95 | -6.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.